Intuitive Surgical [ISRG] vs ResMed [RMD] Detailed Stock Comparison

Intuitive Surgical

NASDAQ
Loading...

ResMed

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Intuitive Surgical wins in 4 metrics, ResMed wins in 15 metrics, with 0 ties. ResMed appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricIntuitive SurgicalResMedBetter
P/E Ratio (TTM)61.3428.41ResMed
Price-to-Book Ratio8.826.65ResMed
Debt-to-Equity Ratio0.0014.27Intuitive Surgical
PEG Ratio2.520.94ResMed
EV/EBITDA47.7921.14ResMed
Profit Margin (TTM)28.51%27.22%Intuitive Surgical
Operating Margin (TTM)30.47%33.87%ResMed
EBITDA Margin (TTM)30.47%33.87%ResMed
Return on Equity16.04%25.86%ResMed
Return on Assets (TTM)9.02%14.02%ResMed
Free Cash Flow (TTM)$1.30B$1.65BResMed
Dividend YieldN/A0.63%N/A
1-Year Return-8.08%18.23%ResMed
Price-to-Sales Ratio (TTM)17.297.71ResMed
Enterprise Value$152.23B$39.33BIntuitive Surgical
EV/Revenue Ratio16.657.64ResMed
Gross Profit Margin (TTM)66.31%60.84%Intuitive Surgical
Revenue per Share (TTM)$26$35ResMed
Earnings per Share (Diluted)$7.16$9.54ResMed
Beta (Stock Volatility)1.620.85ResMed
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Intuitive Surgical vs ResMed Stock Performance Analysis

Loading Price Chart...

Intuitive Surgical
ResMed
Intuitive Surgical Stock Overview | ResMed Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Intuitive Surgical1.13%1.12%-5.56%-18.05%-12.63%-15.46%
ResMed2.14%3.49%2.08%8.11%24.05%21.08%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Intuitive Surgical-8.08%134.79%80.04%749.00%1,275.81%5,565.09%
ResMed18.23%24.38%57.07%409.47%747.03%1,327.45%

News Based Sentiment: Intuitive Surgical vs ResMed

Intuitive Surgical

News based Sentiment: MIXED

September presented a mixed bag for Intuitive Surgical, with positive developments in the SP platform and long-term projections offset by a stock downgrade, price decline, and ongoing tariff concerns. The company is navigating a complex environment, making this a significant month for investors to reassess their positions.

View Intuitive Surgical News Sentiment Analysis

ResMed

News based Sentiment: POSITIVE

ResMed experienced a strong September, marked by positive Q4 earnings, increased dividend payouts, and multiple analyst upgrades, including a 'strong-buy' rating from UBS and a 'Buy' rating with a $330 target from Citigroup. While insider selling occurred, the overall narrative is positive, supported by robust financial performance and strategic initiatives.

View ResMed News Sentiment Analysis

Performance & Financial Health Analysis: Intuitive Surgical vs ResMed

MetricISRGRMD
Market Information
Market Cap i$157.45B$40.08B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i2,576,570840,530
90 Day Avg. Volume i2,410,430936,663
Last Close$443.01$276.64
52 Week Range$425.00 - $616.00$199.92 - $293.81
% from 52W High-28.08%-5.84%
All-Time High$616.00 (Jan 20, 2025)$301.34 (Sep 06, 2021)
% from All-Time High-28.08%-8.20%
Growth Metrics
Quarterly Revenue Growth0.21%0.10%
Quarterly Earnings Growth0.25%0.30%
Financial Health
Profit Margin (TTM) i0.29%0.27%
Operating Margin (TTM) i0.30%0.34%
Return on Equity (TTM) i0.16%0.26%
Debt to Equity (MRQ) i0.0014.27
Cash & Liquidity
Book Value per Share (MRQ)$49.79$40.77
Cash per Share (MRQ)$14.86$8.26
Operating Cash Flow (TTM) i$2.83B$1.75B
Levered Free Cash Flow (TTM) i$1.82B$1.21B
Dividends
Last 12-Month Dividend Yield iN/A0.63%
Last 12-Month Dividend iN/A$1.59

Valuation & Enterprise Metrics Analysis: Intuitive Surgical vs ResMed

MetricISRGRMD
Price Ratios
P/E Ratio (TTM) i61.3428.41
Forward P/E i55.8826.34
PEG Ratio i2.520.94
Price to Sales (TTM) i17.297.71
Price to Book (MRQ) i8.826.65
Market Capitalization
Market Capitalization i$157.45B$40.08B
Enterprise Value i$152.23B$39.33B
Enterprise Value Metrics
Enterprise to Revenue i16.657.64
Enterprise to EBITDA i47.7921.14
Risk & Other Metrics
Beta i1.620.85
Book Value per Share (MRQ) i$49.79$40.77

Financial Statements Comparison: Intuitive Surgical vs ResMed

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)ISRGRMD
Revenue/Sales i$2.44B$1.35B
Cost of Goods Sold i$822.10M$527.93M
Gross Profit i$1.62B$820.07M
Research & Development i$313.30M$86.44M
Operating Income (EBIT) i$743.40M$456.57M
EBITDA i$898.70M$532.89M
Pre-Tax Income i$832.10M$458.05M
Income Tax i$167.90M$78.35M
Net Income (Profit) i$664.20M$379.71M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)ISRGRMD
Cash & Equivalents i$2.57B$1.21B
Total Current Assets i$7.66B$3.51B
Total Current Liabilities i$1.54B$1.02B
Long-Term Debt iN/A$811.41M
Total Shareholders Equity i$17.21B$5.97B
Retained Earnings i$7.14B$6.08B
Property, Plant & Equipment iN/A$288.62M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)ISRGRMD
Operating Cash Flow i$833.10M$441.40M
Capital Expenditures i$-116.60M$-30.59M
Free Cash Flow i$465.00M$504.99M
Debt Repayment iN/A$-5.00M
Common Stock Repurchase iN/A$-100.01M

Short Interest & Institutional Ownership Analysis

MetricISRGRMD
Shares Short i5.72M8.65M
Short Ratio i2.508.77
Short % of Float i0.02%0.07%
Average Daily Volume (10 Day) i2,576,570840,530
Average Daily Volume (90 Day) i2,410,430936,663
Shares Outstanding i356.60M146.39M
Float Shares i356.30M145.48M
% Held by Insiders i0.01%0.01%
% Held by Institutions i0.89%0.65%

Dividend Analysis & Yield Comparison: Intuitive Surgical vs ResMed

MetricISRGRMD
Last 12-Month Dividend iN/A$1.59
Last 12-Month Dividend Yield iN/A0.63%
3-Year Avg Annual Dividend iN/A$1.60
3-Year Avg Dividend Yield iN/A0.23%
3-Year Total Dividends iN/A$4.79
Ex-Dividend DateN/AFeb 13, 2025